GNRH1 and ovarian hyperstimulation syndrome: While reducing the risk of OHSS is critical to avoid delays to life-sparing cancer treatment, a suboptimal response to a GnRH-a trigger could lead to poor outcomes such as low oocyte maturity or empty-follicle syndrome (EFS) [5–11].